```html

Cholecystitis – Comprehensive Medical Guide

Overview

Cholecystitis is the inflammation of the gall‑bladder, a small, pear‑shaped organ located beneath the liver that stores and concentrates bile. The most common form is acute cholecystitis, which develops suddenly and can be life‑threatening if not treated promptly. A less common form, chronic cholecystitis, results from repeated episodes of inflammation and often leads to a thickened, scarred gall‑bladder.

Cholecystitis can affect anyone, but it is most prevalent in adults ages 30‑60 and is more common in women (approximately 2–3 times higher incidence than men). In the United States, acute cholecystitis accounts for roughly 600,000 emergency department visits each year and results in about 70,000 hospitalizations annually.<sup>1</sup>

Symptoms

The presentation of cholecystitis can vary between acute and chronic disease. Below is a complete list of typical signs and symptoms, with brief explanations.

Acute Cholecystitis

• Severe, steady pain in the right upper abdomen (right upper quadrant, RUQ) that may radiate to the right shoulder or back.
• Pain lasting more than 6 hours and often worsening after a fatty meal.
• Nausea and vomiting – the body’s response to biliary irritation.
• Fever (temperature >38 °C/100.4 °F) and chills, reflecting infection.
• Jaundice (yellowing of skin/eyes) – occurs if a gallstone blocks the common bile duct.
• Loss of appetite and generalized malaise.
• Rebound tenderness (pain intensifies when pressure is released) on physical exam – a classic sign of peritoneal irritation.

Chronic Cholecystitis

• Recurrent, milder RUQ discomfort, especially after meals.
• Intermittent nausea or bloating.
• Occasional low‑grade fever, though many patients are afebrile.
• Feelings of fullness or early satiety.

Because symptoms overlap with other abdominal conditions (e.g., peptic ulcer disease, pancreatitis), medical evaluation is essential.

Causes and Risk Factors

Primary Cause – Gallstones

About 90 % of acute cholecystitis cases are triggered by gallstones that obstruct the cystic duct, leading to bile stasis, inflammation, and bacterial overgrowth. The most common bacteria are Escherichia coli, Klebsiella, and Enterococcus species.<sup>2</sup>

Other Causes

• Acalculous cholecystitis: Inflammation without stones, seen in critically ill patients (e.g., after major surgery, severe trauma, or sepsis).
• Gallbladder tumors (rare).
• Bile duct anomalies that impair drainage.

Risk Factors

• Gender: Female (estrogen increases cholesterol saturation in bile).
• Age: Risk rises after 40 years.
• Obesity: Body mass index (BMI) ≥ 30 kg/m² doubles the odds of gallstones.<sup>3</sup>
• Rapid weight loss or fasting (e.g., bariatric surgery, very low‑calorie diets).
• Diet high in fat and cholesterol and low in fiber.
• Family history of gallstones.
• Diabetes mellitus and certain metabolic disorders.
• Pregnancy (increased estrogen and gallbladder stasis).
• Medications such as estrogen therapy, cholesterol‑lowering drugs (e.g., fibrates), and certain antibiotics.

Diagnosis

Diagnosing cholecystitis involves a combination of history, physical examination, laboratory tests, and imaging.

Laboratory Tests

• Complete blood count (CBC): Elevated white blood cells (leukocytosis) suggest infection.
• Liver function tests (LFTs): May show mild elevations in ALT, AST, alkaline phosphatase, or bilirubin if biliary obstruction exists.
• C‑reactive protein (CRP): An inflammatory marker that correlates with disease severity.
• Blood cultures: Reserved for severely ill patients to identify bacteremia.

Imaging Studies

• Ultrasound (US): First‑line test; looks for gallstones, gallbladder wall thickening (>3 mm), pericholecystic fluid, and a positive Murphy’s sign on sonography.
• Hepatobiliary iminodiacetic acid (HIDA) scan: Evaluates cystic duct obstruction; non‑filling of the gallbladder within 30–60 minutes is diagnostic.
• CT scan: Helpful for complicated cases (perforation, abscess) and to rule out other intra‑abdominal pathology.
• Magnetic resonance cholangiopancreatography (MRCP): Non‑invasive view of the biliary tree, useful when choledocholithiasis (common bile duct stones) is suspected.

Diagnostic Criteria

According to the Tokyo Guidelines (2022), a diagnosis of acute cholecystitis requires at least one “local sign of inflammation” (e.g., Murphy’s sign, RUQ pain) and one systemic sign (fever, elevated CRP/WBC), plus imaging evidence of gallbladder inflammation.

Treatment Options

Management is tailored to disease severity, patient comorbidities, and whether the presentation is acute or chronic.

Acute Cholecystitis

1. Hospital admission for monitoring, especially if fever, leukocytosis, or severe pain is present.
2. Fluid resuscitation with intravenous (IV) crystalloids to maintain perfusion.
3. Analgesia: IV acetaminophen or opioids (e.g., morphine) for pain control.
4. Antibiotics (empiric coverage for gram‑negative and anaerobic bacteria):
   • First‑line: Ceftriaxone + Metronidazole, or Piperacillin‑tazobactam, or a fluoroquinolone (e.g., Levofloxacin) + Metronidazole.
   • Tailor based on culture results and renal function.
5. Cholecystectomy (removal of the gallbladder) is the definitive treatment.
   • Laparoscopic cholecystectomy is preferred (90‑95 % success) and can often be performed within 24–72 hours of admission (“early surgery”).
   • In critically ill or unstable patients, delayed surgery after 6‑8 weeks may be safer.

Chronic Cholecystitis

• Elective laparoscopic cholecystectomy is recommended even if symptoms are mild, as recurrent attacks increase the risk of acute complications.
• For patients who cannot undergo surgery, percutaneous cholecystostomy (drain placement under imaging guidance) can control inflammation and infection temporarily.

Lifestyle & Supportive Measures

• Low‑fat diet while symptomatic (≤30 % of total calories from fat).
• Avoid large, greasy meals that stimulate gallbladder contraction.
• Gradual weight loss (½‑1 lb per week) if overweight; rapid loss can worsen biliary stasis.
• Hydration and fiber‑rich foods to promote normal bowel movements.

Living with Cholecystitis

Even after surgery, many patients wonder how life changes. Below are practical tips for the postoperative period and for those managed non‑surgically.

Post‑Surgical Recovery

• Hospital stay: Usually 1–2 days after uncomplicated laparoscopic surgery.
• Activity: Light walking on day‑of‑surgery; avoid heavy lifting (>10 lb) for 2‑4 weeks.
• Diet: Start with clear liquids, progress to a low‑fat, low‑spice diet as tolerated; most patients return to a normal diet within 4‑6 weeks.
• Pain management: Follow prescribed analgesics; avoid NSAIDs if you have renal disease or ulcer risk.
• Monitoring: Watch for fever, increasing abdominal pain, or persistent nausea—contact your surgeon promptly.

Non‑Surgical Management

• Adhere to the diet recommendations above.
• Take prescribed antibiotics exactly as directed; complete the full course.
• Schedule follow‑up imaging (often an ultrasound) 4‑6 weeks after discharge to confirm resolution.
• Maintain regular check‑ups with your primary care provider or gastroenterologist.

Emotional & Lifestyle Adjustments

• Stress can exacerbate gastrointestinal symptoms—consider moderate exercise, mindfulness, or counseling.
• Join support groups (online or local) for gallbladder disease; sharing experiences reduces anxiety.
• Keep a food diary for the first month after treatment to identify any trigger foods.

Prevention

While you cannot completely eliminate the chance of gallstones, several evidence‑based strategies lower the risk of cholecystitis.

• Maintain a healthy weight: Aim for a BMI 18.5‑24.9 kg/m². Gradual weight loss (≤1 lb/week) reduces bile supersaturation.
• Eat a balanced diet: High‑fiber (fruits, vegetables, whole grains), moderate‑fat, and low‑cholesterol meals. The Mediterranean diet has been linked to lower gallstone prevalence.<sup>4</sup>
• Stay physically active: At least 150 minutes of moderate aerobic activity per week lowers gallstone risk.
• Avoid rapid fasting or crash diets: If you need to lose weight quickly for medical reasons, do it under professional supervision.
• Limit estrogen exposure: Discuss risks with your physician if you are on hormone replacement therapy or oral contraceptives.
• Control diabetes and lipid levels: Proper medical management reduces cholesterol saturation of bile.

Complications

If cholecystitis is not promptly treated, inflammation can spread, leading to serious, sometimes life‑threatening problems.

• Gangrene of the gallbladder: Necrosis from loss of blood supply; can perforate.
• Gallbladder perforation: Leads to bile peritonitis, an acute abdominal emergency.
• Abscess formation: Localized collection of pus requiring drainage.
• Fistula formation: Abnormal connections between the gallbladder and adjacent organs (e.g., duodenum, colon).
• Empyema: Pus‑filled gallbladder; higher morbidity.
• Sepsis: Systemic infection with potential organ failure.
• Choledocholithiasis & cholangitis: Stones migrate to the common bile duct, causing jaundice and infection.

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. “Gallbladder disease statistics.” https://www.cdc.gov/nchs/fastats/gallbladder.htm. Accessed May 2026.
2. Mayo Clinic. “Acute cholecystitis.” https://www.mayoclinic.org. Updated 2023.
3. Harvard Health Publishing. “Obesity and gallstone disease.” Harvard Medical School, 2022.
4. American College of Gastroenterology. “Dietary management of gallstone disease.” https://gi.org. 2021.
5. Tokyo Guidelines 2022 for the Management of Acute Cholecystitis. World Journal of Surgery. 2022;46(2):254‑276.

```